Extrait

The purpose of this study is to determine whether the daily administration of a synbiotic (oligofructose and Bifidobacterium animalis subsp. lactis Bb12) for six weeks contributes to improve the glucose tolerance and the low grade inflammation (as reflected as the plasmatic concentrations of ultrasensitive CRP, IL-6, sCD14 and LPS-binding protein) in obese subjects.

Critère d'inclusion

• obesity ,Diabetes Mellitus, Type 2 ,Insulin Resistance ,Metabolic syndrome

Liens

• ictrp
• nct